Fmoc-L-beta-HAsn(Trt)-OH

Online Inquiry

CAT#CP25705
CAS283160-20-3
Synonyms/AliasFmoc-beta-Hoasn(Trt)-OH;283160-20-3;Fmoc-beta-Homoasn(Trt)-OH;FMOC-L-BETA-HOMOASPARAGINE(TRT);Fmoc-beta-Gln(Trt)-OH;(3S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-[tri(phenyl)methylamino]pentanoicacid;Nbeta-Fmoc-Ndelta-trityl-L-homoasparagine;(S)-3-(Fmoc-amino)-N-trityl-valericacid5-amide;AmbotzFAA6640;Fmoc-?-HoAsn(Trt)-OH;Fmoc-|A-HoAsn(Trt)-OH;18505_ALDRICH;Fmoc-L-?-Homoasparagine(Trt);AC1MC547;18505_FLUKA;CTK8B3662;MolPort-003-793-982;ZINC4240251;CF-322;AKOS015948692;RTR-012515;AK-89142;KB-277021;ST24047235;(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-(tritylamino)pentanoicacid
Chemical NameN-beta-(9-Fluorenylmethyloxycarbonyl)-N-gamma-trityl-L-homoasparagine
M.F/FormulaC39H34N2O5
M.W/Mr.610.7
ApplicationPeptide synthesis; Drug screening
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

Background Aclerastide, one angiotensin receptor agonist, is the active ingredient of DSC127 and its general structure is sho ...

 The sodium channel subtypes NaV1.2 and NaV1.6 are the two major forms of excitatory pyramidal neurons in the cer ...

of skin aging Skin aging is an obvious external manifestation of the natural process occurring in tissues and or ...

 Ziconotide (previously called SNX-111), currently marketed under the brand name of Prialt, is the synthetic form ...

  Etomidate, a highly selective intravenous anesthetic agent, was first synthesized at Janssen Pharmaceuticals in ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.